BeBop Sensors Introduces First RoboSkin for Human-Like Sensing of Objects to Any Robot Part

BeBop Sensors, Inc. the world leader in smart fabric sensor technologies, announced today the BeBop Sensors RoboSkin line of skin-like coverings for tactile awareness for humanoid robots and prosthetics.

A true nervous system for robots at less than 1mm thick, RoboSkin is the only technology that fits all robotic body parts: limbs, fingers, feet, head, and torso, to make robots “feel” better. RoboSkin’s advanced fabric-based sensor skin can be shaped to any surface allowing quick tailoring to fit any robot, with spatial resolution and sensitivity that exceeds human abilities for a true partnership between humans and their robot helpers.

The Missing Component to Make Robots More Human – the Sense of Touch

Advances in robotics, such as vision and listening, are missing a key element — the sense of touch, essential for practical human/robot interaction. As robots are quickly becoming part of our world, they need to interact and learn by sense of touch and feel. Flexible, reliable, and highly proprietary, BeBop Sensors’ RoboSkin provides this essential touch factor, with technology based on BeBop’s fabric sensors, with millions of sensors in daily use throughout the world and over 30 U.S. and international patents.

E83Cce06 Bb3E 221B Bc8B F686Abd89E1F

Humanoid Robots — a World Designed with and for Humans

The Census Bureau predicts that for the first time ever, there will be more Americans over the age of 65 than under 18, with Japan having the oldest population with 30% over 65. In addition, “The Great Resignation” shows no sign of slowing down, with record numbers of people leaving the work force. Human-like robots are stepping up to this urgent need, augmenting humans in the workplace, hospitals, and homes; with roles in healthcare, as domestic help, in manufacturing, distribution, biohazards, and even in entertainment and companionship roles. A human shape ensures a robot should be able to perform any human task; to fit through any door and use every human tool. Robots do not need to have the environment made around their needs — robots can do jobs humans want to avoid.

Founder Keith McMillen said, “I have been working with roboticists refining our RoboSkin for 10 years. We are pleased we can make this important contribution to the worldwide effort to bring humanoid robots into our lives to help people live longer, healthier, and more enjoyable lives.”

RoboSkin is available immediately for a variety of applications in robotics and prosthetics, including biohazard, digital health, IoT, VR/AR, automotive, law enforcement, testing, and more. For more information, see the video: https://youtu.be/BWBUhcbEE50

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”